Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...

Art Pappas will speak at the Personalized Medicine in North Carolina: Innovation to Application conference that will be held in Research Triangle Park, NC: "Investors Perspectives on Investments in Personalized Medicine"
News | 05. 11. 2009